Axxess Home Health now enables users to document interventions and goals for COVID-19 vaccine administration when developing a patient’s plan of care. When developing a patient’s plan of care from a physician order or OASIS/non-OASIS assessment, users can select Need for Immunization Plan of...
There is need for effective and affordable vaccines against SARS-CoV-2 to tackle the ongoing pandemic. In this study, we describe a protein nanoparticle vaccine against SARS-CoV-2. The vaccine is based on the display of coronavirus spike glycoprotein rec
Our work provides a basis for further analysis of the protective immunity to SARS-CoV-2 and for understanding the pathogenesis of COVID-19. It also has implications for the development of an effective vaccine for SARS-CoV-2 infection.
We aim to investigate the efficacy of auricular acupressure (AA) therapy in preventing and relieving AEFI after injection of COVID-19 vaccine. Methods The study design is a randomized, multicentre, three-arm controlled, single-blind trial. Participants meeting the inclusion criteria will be ...
Therapy of COVID-19 with modern medicine and vaccine The present clinical methods for COVID-19 treatment mainly include antiviral and antibacterial drugs, anti-inflammatory drugs, anti-SARS-CoV-2 antibody, oxygen therapy, and intestinal microecological agents and plasma from patients in rehabilitation...
As healthy controls, we used plasma samples collected at baseline in a vaccine study performed in early 2019 (n = 32). The RBD protein was cloned and expressed in mammalian cells (Figure S1B) and was validated by ELISA using CR3022, a SARS-specific human monoclonal antibody that cross-...
Available at: https://www.jnj.com/johnson-johnson-single-shot-covid-19-vaccine-granted-conditional-marketing-authorization-by-european-commission 8 Custers, J., Kim, D., et al. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerat...
(2) paid for COVID-19 related services and the costs of higher hygiene standards. Our analysis covers payment adjustments during 2020 only, therefore payments related to the vaccine rollout are not covered. For hospitals, we focused on acute inpatient care, excluding rehabilitation and long-term ...
SARS-CoV-2 is the underlying cause for the COVID-19 pandemic. Like most enveloped RNA viruses, SARS-CoV-2 uses a homotrimeric surface antigen to gain entry into host cells. Here we describe S-Trimer, a native-like trimeric subunit vaccine candidate for C
Recent studies have revealed that the efficacy of mRNA monovalent vaccine after two or three doses against severe infection or death is relatively high, while the induction of cross-neutralizing antibodies against recent Omicron variants infection was less than 50% during the BA.4/5 waves, and ...